From Our Partners
Saturday, July 2, 2022
News on Pathogens and Preparedness
Global Biodefense
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home CBRNE

Understanding Public Exposure to Patients Treated with Radioactive Iodine

by Global Biodefense Staff
April 2, 2013

Thyroid Cancer Treatment - Radioactive IodineThe U.S. Nuclear Regulatory Commission (NRC) is conducting market research to determine the availability and potential technical capability of the business community to manage the collection of data on doses to members of the public exposed to patients treated with Iodine-131. 

Radioactive iodine, mainly the isotope Iodine-131, is used in the diagnosis and treatment of several medical conditions, the primary ones in the present context being treatment of hyperthyroidism and thyroid cancer following thyroidectomy. 

Treatment protocols for these conditions generally call for administration of relatively large doses of Iodine-131, and such patients therefore pose the greatest potential for exposure of others. 

Patients are often released from the hospital following treatment if they meet NRC regulations, with the basic criterion for release being that “the total effective dose equivalent to any other individual from exposure to the released individual is not likely to exceed 5 mSv (0.5 rem).”

Potential sources would be required to execute the following activities: Measure External Doses to Selected Members of the Public; Measure Internal Doses to Selected Members of the Public; Time and Motion Study; Analysis of Data and Final Report; and Technical Support. 

The government is only seeking information on source capabilities at this time and has not issued a formal request for proposals. Further details are available under Solicitation Number: RES-13-092. The response deadline is April 16, 2013.

From Our Partners
Tags: RadiationRFI

Related Posts

Poliovirus Detected in London Sewage: Response Measures Emphasize Wastewater Surveillance and Vaccination Gaps
Outbreak News

Poliovirus Detected in London Sewage: Response Measures Emphasize Wastewater Surveillance and Vaccination Gaps

June 22, 2022
Monkeypox Diagnostics: CDC Authorizes Five Commercial Lab Companies
Biosurveillance

Monkeypox Diagnostics: CDC Authorizes Five Commercial Lab Companies

June 22, 2022
BARDA and JPEO-CBRND Back Cepheid’s Multiplex Test for Influenza, SARS-CoV2 and RSV
Health Security

Resurgent COVID-19, Flu and Other Viruses are Pushing New Zealand’s Health System to the Limit

June 2, 2022
Politics and Pandemic Fatigue Doom California’s Covid Vaccine Mandates
Public Health

Politics and Pandemic Fatigue Doom California’s Covid Vaccine Mandates

May 31, 2022
Load More

Latest News

Poliovirus Detected in London Sewage: Response Measures Emphasize Wastewater Surveillance and Vaccination Gaps

Poliovirus Detected in London Sewage: Response Measures Emphasize Wastewater Surveillance and Vaccination Gaps

June 22, 2022
Monkeypox Diagnostics: CDC Authorizes Five Commercial Lab Companies

Monkeypox Diagnostics: CDC Authorizes Five Commercial Lab Companies

June 22, 2022
UK Health Security Agency Widens Monkeypox Vaccine Umbrella for Outbreak Control

UK Health Security Agency Widens Monkeypox Vaccine Umbrella for Outbreak Control

June 21, 2022
Influenza Research

New Way to Identify Influenza A Virus Lights Up When Specific Virus Targets are Present

June 20, 2022

Subscribe

  • About
  • Contact
  • Privacy
  • Subscribe

© 2022 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe

© 2022 Stemar Media Group LLC